USD 25.65
(-2.51%)
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2023 | 2.17 Billion USD | -15.2% |
2022 | 2.56 Billion USD | -5.25% |
2021 | 2.7 Billion USD | -15.59% |
2020 | 3.2 Billion USD | 73.26% |
2019 | 1.85 Billion USD | 42.28% |
2018 | 1.3 Billion USD | -8.57% |
2017 | 1.42 Billion USD | -8.72% |
2016 | 1.55 Billion USD | 9.33% |
2015 | 1.42 Billion USD | -14.41% |
2014 | 1.66 Billion USD | 380.12% |
2013 | 347 Million USD | -19.3% |
2012 | 430 Million USD | 2587.5% |
2011 | 16 Million USD | -97.51% |
2010 | 642 Million USD | -42.52% |
2009 | 1.11 Billion USD | -17.75% |
2008 | 1.35 Billion USD | 3672.22% |
2007 | 36 Million USD | 140.0% |
2006 | 15 Million USD | -92.89% |
2005 | 211 Million USD | -27.91% |
2004 | 292.69 Million USD | 50.38% |
2003 | 194.64 Million USD | -26.44% |
2002 | 264.6 Million USD | 7.2% |
2001 | 246.82 Million USD | -7.63% |
2000 | 267.2 Million USD | 717.7% |
1999 | 32.67 Million USD | 53.8% |
1998 | 21.24 Million USD | -11.97% |
1997 | 24.13 Million USD | 5.97% |
1996 | 22.77 Million USD | 40.38% |
1995 | 16.22 Million USD | -42.02% |
1994 | 27.98 Million USD | -31.7% |
1993 | 40.97 Million USD | 19.54% |
1992 | 34.27 Million USD | -83.97% |
1991 | 213.87 Million USD | -5.15% |
1990 | 225.49 Million USD | -7.18% |
1989 | 242.93 Million USD | -9.88% |
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2024 Q2 | 3.14 Billion USD | 0.0% |
2023 Q2 | 2.63 Billion USD | 0.0% |
2023 FY | 2.17 Billion USD | -15.2% |
2023 Q4 | 2.17 Billion USD | 0.0% |
2022 Q4 | 2.71 Billion USD | 0.0% |
2022 Q2 | 2.15 Billion USD | 0.0% |
2022 FY | 2.56 Billion USD | -5.25% |
2021 FY | 2.7 Billion USD | -15.59% |
2021 Q2 | 2.91 Billion USD | 0.0% |
2021 Q4 | 2.84 Billion USD | 0.0% |
2020 Q2 | 2.47 Billion USD | 0.0% |
2020 Q4 | 3.35 Billion USD | 0.0% |
2020 FY | 3.2 Billion USD | 73.26% |
2019 FY | 1.85 Billion USD | 42.28% |
2019 Q4 | 1.97 Billion USD | 0.0% |
2019 Q2 | 1.98 Billion USD | 0.0% |
2018 Q4 | 1.3 Billion USD | 0.0% |
2018 Q2 | 1.42 Billion USD | 0.0% |
2018 FY | 1.3 Billion USD | -8.57% |
2017 FY | 1.42 Billion USD | -8.72% |
2017 Q4 | 1.42 Billion USD | 0.0% |
2017 Q2 | 1.6 Billion USD | 0.0% |
2016 Q4 | 1.56 Billion USD | 0.0% |
2016 FY | 1.55 Billion USD | 9.33% |
2016 Q2 | 1.7 Billion USD | 0.0% |
2015 FY | 1.42 Billion USD | -14.41% |
2015 Q2 | 1.53 Billion USD | 0.0% |
2015 Q4 | 1.43 Billion USD | 0.0% |
2014 Q4 | 1.66 Billion USD | 0.0% |
2014 FY | 1.66 Billion USD | 380.12% |
2014 Q2 | 1.98 Billion USD | 0.0% |
2013 Q4 | 347 Million USD | 0.0% |
2013 Q2 | 335 Million USD | 0.0% |
2013 FY | 347 Million USD | -19.3% |
2012 Q4 | 430 Million USD | 2587.5% |
2012 Q1 | 15 Million USD | -6.25% |
2012 FY | 430 Million USD | 2587.5% |
2012 Q2 | 15 Million USD | 0.0% |
2012 Q3 | 16 Million USD | 6.67% |
2011 FY | 16 Million USD | -97.51% |
2011 Q4 | 16 Million USD | -40.74% |
2011 Q3 | 27 Million USD | -6.9% |
2011 Q2 | 29 Million USD | -94.51% |
2011 Q1 | 528 Million USD | -17.76% |
2010 Q1 | 1.01 Billion USD | -9.04% |
2010 Q2 | 1.04 Billion USD | 3.05% |
2010 FY | 642 Million USD | -42.52% |
2010 Q3 | 1.05 Billion USD | 0.67% |
2010 Q4 | 642 Million USD | -39.09% |
2009 FY | 1.11 Billion USD | -17.75% |
2009 Q4 | 1.11 Billion USD | -11.91% |
2009 Q2 | 1.3 Billion USD | 8.67% |
2009 Q3 | 1.26 Billion USD | -2.76% |
2009 Q1 | 1.2 Billion USD | -11.63% |
2008 Q3 | 1.39 Billion USD | 3766.67% |
2008 FY | 1.35 Billion USD | 3672.22% |
2008 Q1 | 37 Million USD | 2.78% |
2008 Q2 | 36 Million USD | -2.7% |
2008 Q4 | 1.35 Billion USD | -2.44% |
2007 Q1 | 21 Million USD | 40.0% |
2007 Q2 | 42 Million USD | 100.0% |
2007 Q4 | 36 Million USD | -10.0% |
2007 Q3 | 40 Million USD | -4.76% |
2007 FY | 36 Million USD | 140.0% |
2006 Q4 | 15 Million USD | -6.25% |
2006 FY | 15 Million USD | -92.89% |
2006 Q1 | 16 Million USD | -87.88% |
2006 Q2 | 16 Million USD | 0.0% |
2006 Q3 | 16 Million USD | 0.0% |
2005 Q4 | 132 Million USD | -29.03% |
2005 Q3 | 186 Million USD | -63.07% |
2005 Q2 | 503.69 Million USD | 155.68% |
2005 Q1 | 197 Million USD | -28.79% |
2005 FY | 211 Million USD | -27.91% |
2004 Q1 | 418.91 Million USD | 115.22% |
2004 FY | 292.69 Million USD | 50.38% |
2004 Q4 | 276.65 Million USD | -19.49% |
2004 Q3 | 343.62 Million USD | -19.39% |
2004 Q2 | 426.25 Million USD | 1.75% |
2003 Q2 | - USD | -100.0% |
2003 Q1 | 563.18 Million USD | 112.84% |
2003 Q3 | - USD | 0.0% |
2003 FY | 194.64 Million USD | -26.44% |
2003 Q4 | 194.64 Million USD | 0.0% |
2002 Q2 | - USD | 0.0% |
2002 Q4 | 264.6 Million USD | 0.0% |
2002 FY | 264.6 Million USD | 7.2% |
2001 FY | 246.82 Million USD | -7.63% |
2001 Q2 | - USD | 0.0% |
2001 Q4 | 246.82 Million USD | 0.0% |
2000 Q2 | - USD | 0.0% |
2000 Q4 | 267.2 Million USD | 0.0% |
2000 FY | 267.2 Million USD | 717.7% |
1999 Q2 | - USD | 0.0% |
1999 Q4 | 32.67 Million USD | 0.0% |
1999 FY | 32.67 Million USD | 53.8% |
1998 FY | 21.24 Million USD | -11.97% |
1997 FY | 24.13 Million USD | 5.97% |
1996 FY | 22.77 Million USD | 40.38% |
1995 FY | 16.22 Million USD | -42.02% |
1994 FY | 27.98 Million USD | -31.7% |
1993 FY | 40.97 Million USD | 19.54% |
1992 FY | 34.27 Million USD | -83.97% |
1991 FY | 213.87 Million USD | -5.15% |
1990 FY | 225.49 Million USD | -7.18% |
1989 FY | 242.93 Million USD | -9.88% |
Name | Long Term Debt | Long Term Debt Difference |
---|---|---|
Abbott Laboratories | 13.59 Billion USD | 84.006% |
Allurion Technologies Inc. | 2.3 Million USD | -94219.167% |
Artivion, Inc. | 305.53 Million USD | -611.875% |
Avanos Medical, Inc. | 159.4 Million USD | -1264.492% |
Butterfly Network, Inc. | 22.83 Million USD | -9424.852% |
Butterfly Network, Inc. | 22.83 Million USD | -9424.852% |
Bio-Rad Laboratories, Inc. | 1.18 Billion USD | -82.857% |
Boston Scientific Corporation | 8.96 Billion USD | 75.728% |
CONMED Corporation | 971.48 Million USD | -123.885% |
Edwards Lifesciences Corporation | 670 Million USD | -224.627% |
Paragon 28, Inc. | 109.79 Million USD | -1880.892% |
Glaukos Corporation | 383.73 Million USD | -466.793% |
Globus Medical, Inc. | 417.4 Million USD | -421.083% |
Inspire Medical Systems, Inc. | 24.84 Million USD | -8653.924% |
Integer Holdings Corporation | 959.92 Million USD | -126.58% |
Medtronic plc | 23.87 Billion USD | 90.891% |
Myomo, Inc. | 115.16 Thousand USD | -1888576.624% |
Nevro Corp. | 211.47 Million USD | -928.51% |
Owlet, Inc. | 22 Thousand USD | -9886263.636% |
Penumbra, Inc. | 220.9 Million USD | -884.568% |
Vicarious Surgical Inc. | 13.78 Million USD | -15678.02% |
Sonendo, Inc. | 14.03 Million USD | -15396.972% |
STERIS plc | 3.12 Billion USD | 30.292% |
Stryker Corporation | 10.9 Billion USD | 80.048% |
Vapotherm, Inc. | 109.97 Million USD | -1877.668% |
Zimmer Biomet Holdings, Inc. | 4.86 Billion USD | 55.32% |